Why this status
- 4 Jul 2025: Trial registered, NCT07052201
The trials
NCT07052201: Dexamethasone Regimens for BPD Prevention in Preterm Infants
- State
- Not started
- Phase
- Phase 3
- People
- 970 planned
- Started
- 1 Feb 2026
- Primary completion
- 31 Jan 2028
- Arms
- Medium-dose tapering regimen
- Results
- None posted
- 4 Jul 2025: Trial registered
How the status changed
- 19 Nov 2026: First set: Trial registered
About the treatment
Kind of treatment: Drug.
Also known as Aeroseb-dex, Ciprodex component dexamethasone, Decaderm, Decadron, Decaspray, Dexa-sine, Dexacidin component dexamethasone, Dexacortal, Dexacortin, Dexamonozon, Dexapos, Dexasite, Dexasone, Dexasporin component dexamethasone, Dexone, Dextenza, Dexycu, Dexamethasone injection, Fortecortin, Hemady, Hexadrol, Isopto-dex, Loverine, Luxazone, Maxidex, Maxitrol component dexamethasone, Ozurdex, Tobradex component dexamethasone, Tobradex st component dexamethasone.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.